A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors
Leap Therapeutics, Inc.
Leap Therapeutics, Inc.
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Northwestern University